Enhanced White Light Endoscopy Versus Conventional White Light Endoscopy for Colorectal Adenoma D⦠(NCT06979232) | Clinical Trial Compass
RecruitingNot Applicable
Enhanced White Light Endoscopy Versus Conventional White Light Endoscopy for Colorectal Adenoma Detection: A Randomized Controlled Trial
China800 participantsStarted 2025-09-20
Plain-language summary
1. Study on Adenoma Detection Rate (ADR) Comparing Enhanced White Light Endoscopy (E-WLI) versus Conventional White Light Endoscopy (WLI);
2. Study Comparing Enhanced White Light Endoscopy (E-WLI) versus Conventional White Light Endoscopy (WLI) for Detection Rates of Sessile Serrated Lesions (SSLs), Total Polyp Detection Rate, and Advanced Adenoma Detection Rate;
3. Study on Polyp Characteristics (Size, Location, etc.) Observed Using Conventional White Light Endoscopy (WLI) and Enhanced White Light Endoscopy (E-WLI).
Who can participate
Age range45 Years ā 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1\. Male or female aged 45 to 85
* 2\. Patients undergoing colonoscopy for colorectal cancer screening, positive fecal immunochemical test (FIT) results, gastrointestinal symptoms, or follow-up examination after colorectal polyp treatment
* 3\. Capable of providing informed consent and agreeing to participate
* 4\. Able and willing to follow all research processes
Exclusion Criteria:
* 1\. Participated in other clinical trials, signed informed consent form, and in the follow-up period of other clinical trials;
* 2\. Participated in clinical trials of drugs and is in the discontinuation period of experimental or control drugs;
* 3\. Have had drug or alcohol abuse or psychological disorders in the past five years.
* 4\. Pregnant or lactating patients;
* 5\. Known to have polyposis syndrome;
* 6\. Patients with gastrointestinal bleeding;
* 7\. Previous history of inflammatory bowel disease, colorectal cancer, or colorectal surgery;
* 8.Patients with contraindications to tissue biopsy;
* 9\. History of allergies to the ingredients in intestinal cleansers;
* 10\. Individuals with conditions such as intestinal obstruction or perforation, toxic megacolon, heart failure (grade III or IV), severe cardiovascular disease, severe liver failure, or renal insufficiency, among others.
* 11\. Researchers believe that patients are not suitable to participate in the trial.
What they're measuring
1
Adenoma detection rate (ADR)
Timeframe: 14 days
Trial details
NCT IDNCT06979232
SponsorShanghai Jiao Tong University School of Medicine